HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (5) Citing Articles via Google Scholar Google Scholar Articles by Nakamura, S. Articles by Tsubota, K. Search for Related Content PubMed PubMed Citation Articles by Nakamura, S. Articles by Tsubota, K.

D-ß-Hydroxybutyrate Protects against Corneal Epithelial Disorders in a Rat Dry Eye Model with Jogging Board

¹From the Ophtecs Corporation, Hyogo, Japan; the ²Department of Veterinary Anatomy, Faculty of Agriculture, Tottori University, Tottori, Japan; and the ³Department of Ophthalmology, Keio University, School of Medicine, Tokyo, Japan.

PURPOSE. The purpose of this study was to establish a rat dry eye model of corneal epithelial disorders by inducing improper tear dynamics and change in blink frequency. The protective effect of D-ß-hydroxybutyrate (HBA) on the corneal epithelia was also investigated.

METHODS. A series of treatments were performed under continuous exposure to low-humidity airflow. Rats were placed on a jogging board (JB) made of a plastic pipe for 7.5 h/d, and, for 16.5 hours, they were placed in individual cages without JB treatment. The resultant changes in tear dynamics and corneal epithelial structure were then analyzed. Five days after the rats were exposed to the treatment, eyes that showed corneal fluorescein staining were examined, to investigate the effect of HBA, by administration of eye drops containing 80 mM HBA four times daily during JB treatment for 5 days.

RESULTS. Significant reductions in blink frequency, Schirmer score, and tear clearance were recorded during JB treatment in eyes that showed persistent punctate staining of almost one half of the corneal surface. The application of HBA-containing eye drops significantly reduced the punctate staining compared with the initial or phosphate-buffered saline–treated eyes.

CONCLUSIONS. This rat dry eye model, established by repeated JB treatment in desiccating conditions, induced abnormal tear dynamics and superficial punctate keratopathy similar to that in humans. These findings suggest the potential clinical application of HBA in corneal surface epithelial disorders in patients with moderate to mild dry eye.

This article has been cited by other articles:

				M. J. Gonzalez-Garcia, A. Gonzalez-Saiz, Beatriz de la Fuente, A. Morilla-Grasa, A. Mayo-Iscar, J. San-Jose, J. Feijo, M. E. Stern, and M. Calonge Exposure to a Controlled Adverse Environment Impairs the Ocular Surface of Subjects with Minimally Symptomatic Dry Eye Invest. Ophthalmol. Vis. Sci., September 1, 2007; 48(9): 4026 - 4032. [Abstract] [Full Text] [PDF]

				S. Nakamura, M. Shibuya, H. Nakashima, R. Hisamura, N. Masuda, T. Imagawa, M. Uehara, and K. Tsubota Involvement of Oxidative Stress on Corneal Epithelial Alterations in a Blink-Suppressed Dry Eye Invest. Ophthalmol. Vis. Sci., April 1, 2007; 48(4): 1552 - 1558. [Abstract] [Full Text] [PDF]

				O. Suwan-apichon, M. Rizen, R. Rangsin, S. Herretes, J. M. G. Reyes, K. Lekhanont, and R. S. Chuck Botulinum Toxin B-Induced Mouse Model of Keratoconjunctivitis Sicca Invest. Ophthalmol. Vis. Sci., January 1, 2006; 47(1): 133 - 139. [Abstract] [Full Text] [PDF]